+1 (704) 266-3234

Global Coronary Intervention Drug Eluting Stent Market Growth 2021-2026

Published on: Apr 2021 | From USD $2900 | Published By: LP INFORMATION INC | Number Of Pages: 175

According to this latest study, the 2021 growth of Coronary Intervention Drug Eluting Stent will have significant change from previous year. By the most conservative estimates of global Coronary Intervention Drug Eluting Stent market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Coronary Intervention Drug Eluting Stent market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Coronary Intervention Drug Eluting Stent market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Below 40 µm
40 µm- 65 µm
Above 65 µm

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Synlas GmbH
YILSON
BrosMed Medical
SCITECH Medical
Wellinq
Degania Silicone
Alvimedica
Interventional Medical Device Solutions
Comed BV
iVascular
LEPU Medical
Eurocor Tech GmbH
OrbusNeich
Endocor GmbH
Meril Life Sciences
Acrostak
Boston Scientific Corporation
B. Braun
Biotronik
Abbott
MicroPort Medical Group
Philips
Terumo Corporation

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Coronary Intervention Drug Eluting Stent Consumption 2016-2026
2.1.2 Coronary Intervention Drug Eluting Stent Consumption CAGR by Region
2.2 Coronary Intervention Drug Eluting Stent Segment by Type
2.2.1 Below 40 µm
2.2.2 40 µm- 65 µm
2.2.3 Above 65 µm
2.3 Coronary Intervention Drug Eluting Stent Sales by Type
2.3.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)
2.3.2 Global Coronary Intervention Drug Eluting Stent Revenue and Market Share by Type (2016-2021)
2.3.3 Global Coronary Intervention Drug Eluting Stent Sale Price by Type (2016-2021)
2.4 Coronary Intervention Drug Eluting Stent Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Coronary Intervention Drug Eluting Stent Sales by Application
2.5.1 Global Coronary Intervention Drug Eluting Stent Sale Market Share by Application (2016-2021)
2.5.2 Global Coronary Intervention Drug Eluting Stent Revenue and Market Share by Application (2016-2021)
2.5.3 Global Coronary Intervention Drug Eluting Stent Sale Price by Application (2016-2021)

3 Global Coronary Intervention Drug Eluting Stent by Company
3.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Company
3.1.1 Global Coronary Intervention Drug Eluting Stent Sales by Company (2019-2021)
3.1.2 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Company (2019-2021)
3.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Company
3.2.1 Global Coronary Intervention Drug Eluting Stent Revenue by Company (2019-2021)
3.2.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Company (2019-2021)
3.3 Global Coronary Intervention Drug Eluting Stent Sale Price by Company
3.4 Global Manufacturers Coronary Intervention Drug Eluting Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Coronary Intervention Drug Eluting Stent Product Location Distribution
3.4.2 Players Coronary Intervention Drug Eluting Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Coronary Intervention Drug Eluting Stent by Region
4.1 Global Coronary Intervention Drug Eluting Stent by Region
4.1.1 Global Coronary Intervention Drug Eluting Stent Sales by Region
4.1.2 Global Coronary Intervention Drug Eluting Stent Revenue by Region
4.2 Americas Coronary Intervention Drug Eluting Stent Sales Growth
4.3 APAC Coronary Intervention Drug Eluting Stent Sales Growth
4.4 Europe Coronary Intervention Drug Eluting Stent Sales Growth
4.5 Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Growth

5 Americas
5.1 Americas Coronary Intervention Drug Eluting Stent Sales by Country
5.1.1 Americas Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021)
5.1.2 Americas Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021)
5.2 Americas Coronary Intervention Drug Eluting Stent Sales by Type
5.3 Americas Coronary Intervention Drug Eluting Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Coronary Intervention Drug Eluting Stent Sales by Region
6.1.1 APAC Coronary Intervention Drug Eluting Stent Sales by Region (2016-2021)
6.1.2 APAC Coronary Intervention Drug Eluting Stent Revenue by Region (2016-2021)
6.2 APAC Coronary Intervention Drug Eluting Stent Sales by Type
6.3 APAC Coronary Intervention Drug Eluting Stent Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Coronary Intervention Drug Eluting Stent by Country
7.1.1 Europe Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021)
7.1.2 Europe Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021)
7.2 Europe Coronary Intervention Drug Eluting Stent Sales by Type
7.3 Europe Coronary Intervention Drug Eluting Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Coronary Intervention Drug Eluting Stent by Country
8.1.1 Middle East & Africa Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021)
8.1.2 Middle East & Africa Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021)
8.2 Middle East & Africa Coronary Intervention Drug Eluting Stent Sales by Type
8.3 Middle East & Africa Coronary Intervention Drug Eluting Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Coronary Intervention Drug Eluting Stent Distributors
10.3 Coronary Intervention Drug Eluting Stent Customer

11 Global Coronary Intervention Drug Eluting Stent Market Forecast
11.1 Global Coronary Intervention Drug Eluting Stent Forecast by Region
11.1.1 Global Coronary Intervention Drug Eluting Stent Forecast by Regions (2021-2026)
11.2.2 Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Coronary Intervention Drug Eluting Stent Forecast by Type
11.7 Global Coronary Intervention Drug Eluting Stent Forecast by Application

12 Key Players Analysis
12.1 Synlas GmbH
12.1.1 Synlas GmbH Company Information
12.1.2 Synlas GmbH Coronary Intervention Drug Eluting Stent Product Offered
12.1.3 Synlas GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Synlas GmbH Main Business Overview
12.1.5 Synlas GmbH Latest Developments
12.2 YILSON
12.2.1 YILSON Company Information
12.2.2 YILSON Coronary Intervention Drug Eluting Stent Product Offered
12.2.3 YILSON Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 YILSON Main Business Overview
12.2.5 YILSON Latest Developments
12.3 BrosMed Medical
12.3.1 BrosMed Medical Company Information
12.3.2 BrosMed Medical Coronary Intervention Drug Eluting Stent Product Offered
12.3.3 BrosMed Medical Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 BrosMed Medical Main Business Overview
12.3.5 BrosMed Medical Latest Developments
12.4 SCITECH Medical
12.4.1 SCITECH Medical Company Information
12.4.2 SCITECH Medical Coronary Intervention Drug Eluting Stent Product Offered
12.4.3 SCITECH Medical Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 SCITECH Medical Main Business Overview
12.4.5 SCITECH Medical Latest Developments
12.5 Wellinq
12.5.1 Wellinq Company Information
12.5.2 Wellinq Coronary Intervention Drug Eluting Stent Product Offered
12.5.3 Wellinq Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Wellinq Main Business Overview
12.5.5 Wellinq Latest Developments
12.6 Degania Silicone
12.6.1 Degania Silicone Company Information
12.6.2 Degania Silicone Coronary Intervention Drug Eluting Stent Product Offered
12.6.3 Degania Silicone Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Degania Silicone Main Business Overview
12.6.5 Degania Silicone Latest Developments
12.7 Alvimedica
12.7.1 Alvimedica Company Information
12.7.2 Alvimedica Coronary Intervention Drug Eluting Stent Product Offered
12.7.3 Alvimedica Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Alvimedica Main Business Overview
12.7.5 Alvimedica Latest Developments
12.8 Interventional Medical Device Solutions
12.8.1 Interventional Medical Device Solutions Company Information
12.8.2 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Product Offered
12.8.3 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Interventional Medical Device Solutions Main Business Overview
12.8.5 Interventional Medical Device Solutions Latest Developments
12.9 Comed BV
12.9.1 Comed BV Company Information
12.9.2 Comed BV Coronary Intervention Drug Eluting Stent Product Offered
12.9.3 Comed BV Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Comed BV Main Business Overview
12.9.5 Comed BV Latest Developments
12.10 iVascular
12.10.1 iVascular Company Information
12.10.2 iVascular Coronary Intervention Drug Eluting Stent Product Offered
12.10.3 iVascular Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 iVascular Main Business Overview
12.10.5 iVascular Latest Developments
12.11 LEPU Medical
12.11.1 LEPU Medical Company Information
12.11.2 LEPU Medical Coronary Intervention Drug Eluting Stent Product Offered
12.11.3 LEPU Medical Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 LEPU Medical Main Business Overview
12.11.5 LEPU Medical Latest Developments
12.12 Eurocor Tech GmbH
12.12.1 Eurocor Tech GmbH Company Information
12.12.2 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Product Offered
12.12.3 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Eurocor Tech GmbH Main Business Overview
12.12.5 Eurocor Tech GmbH Latest Developments
12.13 OrbusNeich
12.13.1 OrbusNeich Company Information
12.13.2 OrbusNeich Coronary Intervention Drug Eluting Stent Product Offered
12.13.3 OrbusNeich Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 OrbusNeich Main Business Overview
12.13.5 OrbusNeich Latest Developments
12.14 Endocor GmbH
12.14.1 Endocor GmbH Company Information
12.14.2 Endocor GmbH Coronary Intervention Drug Eluting Stent Product Offered
12.14.3 Endocor GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Endocor GmbH Main Business Overview
12.14.5 Endocor GmbH Latest Developments
12.15 Meril Life Sciences
12.15.1 Meril Life Sciences Company Information
12.15.2 Meril Life Sciences Coronary Intervention Drug Eluting Stent Product Offered
12.15.3 Meril Life Sciences Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Meril Life Sciences Main Business Overview
12.15.5 Meril Life Sciences Latest Developments
12.16 Acrostak
12.16.1 Acrostak Company Information
12.16.2 Acrostak Coronary Intervention Drug Eluting Stent Product Offered
12.16.3 Acrostak Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Acrostak Main Business Overview
12.16.5 Acrostak Latest Developments
12.17 Boston Scientific Corporation
12.17.1 Boston Scientific Corporation Company Information
12.17.2 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Product Offered
12.17.3 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Boston Scientific Corporation Main Business Overview
12.17.5 Boston Scientific Corporation Latest Developments
12.18 B. Braun
12.18.1 B. Braun Company Information
12.18.2 B. Braun Coronary Intervention Drug Eluting Stent Product Offered
12.18.3 B. Braun Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 B. Braun Main Business Overview
12.18.5 B. Braun Latest Developments
12.19 Biotronik
12.19.1 Biotronik Company Information
12.19.2 Biotronik Coronary Intervention Drug Eluting Stent Product Offered
12.19.3 Biotronik Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Biotronik Main Business Overview
12.19.5 Biotronik Latest Developments
12.20 Abbott
12.20.1 Abbott Company Information
12.20.2 Abbott Coronary Intervention Drug Eluting Stent Product Offered
12.20.3 Abbott Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Abbott Main Business Overview
12.20.5 Abbott Latest Developments
12.21 MicroPort Medical Group
12.21.1 MicroPort Medical Group Company Information
12.21.2 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Product Offered
12.21.3 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.21.4 MicroPort Medical Group Main Business Overview
12.21.5 MicroPort Medical Group Latest Developments
12.22 Philips
12.22.1 Philips Company Information
12.22.2 Philips Coronary Intervention Drug Eluting Stent Product Offered
12.22.3 Philips Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.22.4 Philips Main Business Overview
12.22.5 Philips Latest Developments
12.23 Terumo Corporation
12.23.1 Terumo Corporation Company Information
12.23.2 Terumo Corporation Coronary Intervention Drug Eluting Stent Product Offered
12.23.3 Terumo Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)
12.23.4 Terumo Corporation Main Business Overview
12.23.5 Terumo Corporation Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Coronary Intervention Drug Eluting Stent Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Below 40 µm
Table 3. Major Players of 40 µm- 65 µm
Table 4. Major Players of Above 65 µm
Table 5. Global Coronary Intervention Drug Eluting Stent Sales by Type (2016-2021) & (K Units)
Table 6. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)
Table 7. Global Coronary Intervention Drug Eluting Stent Revenue by Type (2016-2021) & ($ million)
Table 8. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Type (2016-2021)
Table 9. Global Coronary Intervention Drug Eluting Stent Sale Price by Type (2016-2021)
Table 10. Global Coronary Intervention Drug Eluting Stent Sales by Application (2016-2021) & (K Units)
Table 11. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)
Table 12. Global Coronary Intervention Drug Eluting Stent Value by Application (2016-2021)
Table 13. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Application (2016-2021)
Table 14. Global Coronary Intervention Drug Eluting Stent Sale Price by Application (2016-2021)
Table 15. Global Coronary Intervention Drug Eluting Stent Sales by Company (2019-2021) & (K Units)
Table 16. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Company (2019-2021)
Table 17. Global Coronary Intervention Drug Eluting Stent Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Company (2019-2021)
Table 19. Global Coronary Intervention Drug Eluting Stent Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Coronary Intervention Drug Eluting Stent Producing Area Distribution and Sales Area
Table 21. Players Coronary Intervention Drug Eluting Stent Products Offered
Table 22. Coronary Intervention Drug Eluting Stent Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Coronary Intervention Drug Eluting Stent Sales by Region (2016-2021) (K Units)
Table 26. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Region (2016-2021)
Table 27. Global Coronary Intervention Drug Eluting Stent Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Region (2016-2021)
Table 29. Americas Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021) & (K Units)
Table 30. Americas Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2016-2021)
Table 31. Americas Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2016-2021)
Table 33. Americas Coronary Intervention Drug Eluting Stent Sales by Type (2016-2021) & (K Units)
Table 34. Americas Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)
Table 35. Americas Coronary Intervention Drug Eluting Stent Sales by Application (2016-2021) & (K Units)
Table 36. Americas Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)
Table 37. APAC Coronary Intervention Drug Eluting Stent Sales by Region (2016-2021) & (K Units)
Table 38. APAC Coronary Intervention Drug Eluting Stent Sales Market Share by Region (2016-2021)
Table 39. APAC Coronary Intervention Drug Eluting Stent Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Coronary Intervention Drug Eluting Stent Revenue Market Share by Region (2016-2021)
Table 41. APAC Coronary Intervention Drug Eluting Stent Sales by Type (2016-2021) & (K Units)
Table 42. APAC Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)
Table 43. APAC Coronary Intervention Drug Eluting Stent Sales by Application (2016-2021) & (K Units)
Table 44. APAC Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)
Table 45. Europe Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021) & (K Units)
Table 46. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2016-2021)
Table 47. Europe Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2016-2021)
Table 49. Europe Coronary Intervention Drug Eluting Stent Sales by Type (2016-2021) & (K Units)
Table 50. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)
Table 51. Europe Coronary Intervention Drug Eluting Stent Sales by Application (2016-2021) & (K Units)
Table 52. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Coronary Intervention Drug Eluting Stent
Table 62. Key Application and Potential Industries of Coronary Intervention Drug Eluting Stent
Table 63. Key Challenges of Coronary Intervention Drug Eluting Stent
Table 64. Key Trends of Coronary Intervention Drug Eluting Stent
Table 65. Coronary Intervention Drug Eluting Stent Distributors List
Table 66. Coronary Intervention Drug Eluting Stent Customer List
Table 67. Global Coronary Intervention Drug Eluting Stent Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Coronary Intervention Drug Eluting Stent Consumption Market Forecast by Region
Table 69. Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Coronary Intervention Drug Eluting Stent Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Coronary Intervention Drug Eluting Stent Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Coronary Intervention Drug Eluting Stent Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Coronary Intervention Drug Eluting Stent Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Coronary Intervention Drug Eluting Stent Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Coronary Intervention Drug Eluting Stent Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Coronary Intervention Drug Eluting Stent Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Coronary Intervention Drug Eluting Stent Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Coronary Intervention Drug Eluting Stent Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Coronary Intervention Drug Eluting Stent Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Coronary Intervention Drug Eluting Stent Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Coronary Intervention Drug Eluting Stent Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Coronary Intervention Drug Eluting Stent Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Coronary Intervention Drug Eluting Stent Revenue Market Share Forecast by Application (2021-2026)
Table 87. Synlas GmbH Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 88. Synlas GmbH Coronary Intervention Drug Eluting Stent Product Offered
Table 89. Synlas GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Synlas GmbH Main Business
Table 91. Synlas GmbH Latest Developments
Table 92. YILSON Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 93. YILSON Coronary Intervention Drug Eluting Stent Product Offered
Table 94. YILSON Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. YILSON Main Business
Table 96. YILSON Latest Developments
Table 97. BrosMed Medical Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 98. BrosMed Medical Coronary Intervention Drug Eluting Stent Product Offered
Table 99. BrosMed Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. BrosMed Medical Main Business
Table 101. BrosMed Medical Latest Developments
Table 102. SCITECH Medical Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 103. SCITECH Medical Coronary Intervention Drug Eluting Stent Product Offered
Table 104. SCITECH Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. SCITECH Medical Main Business
Table 106. SCITECH Medical Latest Developments
Table 107. Wellinq Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 108. Wellinq Coronary Intervention Drug Eluting Stent Product Offered
Table 109. Wellinq Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Wellinq Main Business
Table 111. Wellinq Latest Developments
Table 112. Degania Silicone Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 113. Degania Silicone Coronary Intervention Drug Eluting Stent Product Offered
Table 114. Degania Silicone Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Degania Silicone Main Business
Table 116. Degania Silicone Latest Developments
Table 117. Alvimedica Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 118. Alvimedica Coronary Intervention Drug Eluting Stent Product Offered
Table 119. Alvimedica Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Alvimedica Main Business
Table 121. Alvimedica Latest Developments
Table 122. Interventional Medical Device Solutions Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 123. Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Product Offered
Table 124. Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. Interventional Medical Device Solutions Main Business
Table 126. Interventional Medical Device Solutions Latest Developments
Table 127. Comed BV Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 128. Comed BV Coronary Intervention Drug Eluting Stent Product Offered
Table 129. Comed BV Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. Comed BV Main Business
Table 131. Comed BV Latest Developments
Table 132. iVascular Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 133. iVascular Coronary Intervention Drug Eluting Stent Product Offered
Table 134. iVascular Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. iVascular Main Business
Table 136. iVascular Latest Developments
Table 137. LEPU Medical Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 138. LEPU Medical Coronary Intervention Drug Eluting Stent Product Offered
Table 139. LEPU Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. LEPU Medical Main Business
Table 141. LEPU Medical Latest Developments
Table 142. Eurocor Tech GmbH Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 143. Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Product Offered
Table 144. Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 145. Eurocor Tech GmbH Main Business
Table 146. Eurocor Tech GmbH Latest Developments
Table 147. OrbusNeich Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 148. OrbusNeich Coronary Intervention Drug Eluting Stent Product Offered
Table 149. OrbusNeich Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 150. OrbusNeich Main Business
Table 151. OrbusNeich Latest Developments
Table 152. Endocor GmbH Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 153. Endocor GmbH Coronary Intervention Drug Eluting Stent Product Offered
Table 154. Endocor GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 155. Endocor GmbH Main Business
Table 156. Endocor GmbH Latest Developments
Table 157. Meril Life Sciences Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 158. Meril Life Sciences Coronary Intervention Drug Eluting Stent Product Offered
Table 159. Meril Life Sciences Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 160. Meril Life Sciences Main Business
Table 161. Meril Life Sciences Latest Developments
Table 162. Acrostak Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 163. Acrostak Coronary Intervention Drug Eluting Stent Product Offered
Table 164. Acrostak Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 165. Acrostak Main Business
Table 166. Acrostak Latest Developments
Table 167. Boston Scientific Corporation Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 168. Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Product Offered
Table 169. Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 170. Boston Scientific Corporation Main Business
Table 171. Boston Scientific Corporation Latest Developments
Table 172. B. Braun Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 173. B. Braun Coronary Intervention Drug Eluting Stent Product Offered
Table 174. B. Braun Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 175. B. Braun Main Business
Table 176. B. Braun Latest Developments
Table 177. Biotronik Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 178. Biotronik Coronary Intervention Drug Eluting Stent Product Offered
Table 179. Biotronik Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 180. Biotronik Main Business
Table 181. Biotronik Latest Developments
Table 182. Abbott Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 183. Abbott Coronary Intervention Drug Eluting Stent Product Offered
Table 184. Abbott Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 185. Abbott Main Business
Table 186. Abbott Latest Developments
Table 187. MicroPort Medical Group Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 188. MicroPort Medical Group Coronary Intervention Drug Eluting Stent Product Offered
Table 189. MicroPort Medical Group Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 190. MicroPort Medical Group Main Business
Table 191. MicroPort Medical Group Latest Developments
Table 192. Philips Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 193. Philips Coronary Intervention Drug Eluting Stent Product Offered
Table 194. Philips Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 195. Philips Main Business
Table 196. Philips Latest Developments
Table 197. Terumo Corporation Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 198. Terumo Corporation Coronary Intervention Drug Eluting Stent Product Offered
Table 199. Terumo Corporation Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 200. Terumo Corporation Main Business
Table 201. Terumo Corporation Latest Developments
List of Figures
Figure 1. Picture of Coronary Intervention Drug Eluting Stent
Figure 2. Coronary Intervention Drug Eluting Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Coronary Intervention Drug Eluting Stent Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Coronary Intervention Drug Eluting Stent Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Coronary Intervention Drug Eluting Stent Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Below 40 µm
Figure 10. Product Picture of 40 µm- 65 µm
Figure 11. Product Picture of Above 65 µm
Figure 12. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type in 2020
Figure 13. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Type (2016-2021)
Figure 14. Coronary Intervention Drug Eluting Stent Consumed in Hospital
Figure 15. Global Coronary Intervention Drug Eluting Stent Market: Hospital (2016-2021) & (K Units)
Figure 16. Coronary Intervention Drug Eluting Stent Consumed in Clinic
Figure 17. Global Coronary Intervention Drug Eluting Stent Market: Clinic (2016-2021) & (K Units)
Figure 18. Coronary Intervention Drug Eluting Stent Consumed in Others
Figure 19. Global Coronary Intervention Drug Eluting Stent Market: Others (2016-2021) & (K Units)
Figure 20. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)
Figure 21. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Application in 2020
Figure 22. Coronary Intervention Drug Eluting Stent Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Company in 2020
Figure 24. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Regions (2016-2021)
Figure 25. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Region in 2020
Figure 26. Americas Coronary Intervention Drug Eluting Stent Sales 2016-2021 (K Units)
Figure 27. Americas Coronary Intervention Drug Eluting Stent Revenue 2016-2021 ($ Millions)
Figure 28. APAC Coronary Intervention Drug Eluting Stent Sales 2016-2021 (K Units)
Figure 29. APAC Coronary Intervention Drug Eluting Stent Revenue 2016-2021 ($ Millions)
Figure 30. Europe Coronary Intervention Drug Eluting Stent Sales 2016-2021 (K Units)
Figure 31. Europe Coronary Intervention Drug Eluting Stent Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Coronary Intervention Drug Eluting Stent Revenue 2016-2021 ($ Millions)
Figure 34. Americas Coronary Intervention Drug Eluting Stent Sales Market Share by Country in 2020
Figure 35. Americas Coronary Intervention Drug Eluting Stent Revenue Market Share by Country in 2020
Figure 36. Americas Coronary Intervention Drug Eluting Stent Sales Market Share by Type in 2020
Figure 37. Americas Coronary Intervention Drug Eluting Stent Sales Market Share by Application in 2020
Figure 38. United States Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Coronary Intervention Drug Eluting Stent Sales Market Share by Region in 2020
Figure 43. APAC Coronary Intervention Drug Eluting Stent Revenue Market Share by Regions in 2020
Figure 44. APAC Coronary Intervention Drug Eluting Stent Sales Market Share by Type in 2020
Figure 45. APAC Coronary Intervention Drug Eluting Stent Sales Market Share by Application in 2020
Figure 46. China Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Country in 2020
Figure 53. Europe Coronary Intervention Drug Eluting Stent Revenue Market Share by Country in 2020
Figure 54. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Type in 2020
Figure 55. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Application in 2020
Figure 56. Germany Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Coronary Intervention Drug Eluting Stent Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Application in 2020
Figure 65. Egypt Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.